Detalhe da pesquisa
1.
Intensity-modulated radiotherapy and cisplatin-based chemotherapy for anal cancer: long-term outcomes at a single institution.
Int J Colorectal Dis
; 38(1): 123, 2023 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162567
2.
Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy.
Tumori
; : 3008916241252544, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769916
3.
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report.
Tumori
; 110(1): 34-43, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182553
4.
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique.
J Cancer Res Clin Oncol
; 148(4): 823-835, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989858
5.
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction.
Phys Med
; 90: 66-72, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563833
6.
A single phantom, a single statistical method for low-contrast detectability assessment.
Phys Med
; 91: 28-42, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710789
7.
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer.
Radiother Oncol
; 128(2): 315-320, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945720